Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Selenophosphate synthetase 1 pseudogene 4 (SEPHS1P4) is a **pseudogene**, meaning it is a DNA segment similar to a functional gene (in this case, likely selenophosphate synthetase 1) but is generally nonfunctional due to disabling mutations or absence of regulatory elements[1][3][4]. Pseudogenes like SEPHS1P4 do not encode functional proteins and are not considered therapeutic targets. Most have no role in cellular processes; however, some pseudogenes can, in rare instances, impact gene regulation by acting as decoys for regulatory RNAs or by producing regulatory transcripts[2][4]. SEPHS1P4 itself has no established molecular function, drug interactions, biomarker status, or safety concerns and is most useful as a genomic annotation rather than a functional biotarget[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Selenophosphate synthetase 1 pseudogene 4 (SEPHS1P4).